title: No change in circulating osteoprotegerin levels by intravenous calcitriol therapy among dialysis patients with secondary hyperparathyroidism.
authors.forename: H
authors.initials: H
authors.lastname: Nishi
authors.forename: T
authors.initials: T
authors.lastname: Nii-Kono
authors.forename: K
authors.initials: K
authors.lastname: Ikeda
authors.forename: A
authors.initials: A
authors.lastname: Fujimori
authors.forename: M
authors.initials: M
authors.lastname: Fukagawa
mesh_terms: D002117:Calcitriol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy*; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear / Q000097:blood*; D018124:Receptors, Tumor Necrosis Factor / Q000097:blood*; D006435:Renal Dialysis; D016896:Treatment Outcome
chemical_list: D006023:Glycoproteins; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human; D002117:Calcitriol; C051883:maxacalcitol